Net Medical Announces Preliminary Results for Fourth Quarter 2021

Rhea-AI Summary

Net Medical Xpress Solutions (OTC PINK:NMXS) reported strong preliminary results for the fourth fiscal quarter of 2021, achieving a net income of $301,285 and total revenue of $821,399.

The company experienced high demand for COVID testing through its advanced mobile testing labs, utilizing bioMerieux's proprietary PCR testing for rapid, certified results. This FDA-approved test can detect 22 viral pathogens, including COVID-19, influenza, and the common cold.

Positive

• Net income of $301,285 in Q4 2021.
• Total revenue reached $821,399.
• High demand for COVID testing services boosts business growth.
• Use of FDA-approved PCR testing module enhances service credibility.

Negative

• None.

Leaning on two decades of experience connecting providers with the patients who need them, Net Medical's business is unique and growing

ALBUQUERQUE, NM / ACCESSWIRE / February 22, 2022 / Net Medical Xpress Solutions (OTC PINK:NMXS) said today that unaudited preliminary numbers show the company recorded net income of $301,285 in the fourth fiscal quarter ending December 31, 2021. Total revenue was $821,399.

Net Medical CEO Dick Govatski said, "Demand was high for Covid tests provided through our state-of-the-art mobile testing labs. Our patients benefited from our use of bioMerieux's proprietary PCR testing module that provides quick certified results that can be used for travel and other purposes. It is the only FDA approved test that can detect and identify 22 separate viral pathogens including Covid, influenza and the common cold."

For more information, call 505-255-1999. X 320. Visit www.netmedical.com. Email ir@netmedical.com

About Net Medical - publicly traded (OTC Pink:NMXS) since 1999.

Net Medical Xpress has two operating units. Net Medical Xpress provides telemedicine solutions for hospitals, nursing homes, specialty hospitals and other medical facilities. The company specializes in teleneurology, teleneurosurgery, telecardiology, teleorthopedics, telewoundcare and telenephrology. We maintain a 24/7/365 call center, software developers, and telemedicine platforms. In additional, Net Medical Labs is a moderate complex CLIA certified lab that specializes in virus testing and diagnostics. The company uses bioMerieux's proprietary PCR testing module that is the only test that can detect 22 separate viral pathogens and has been approved by the FDA. The company's mobile fleet of vans is utilized to provide statewide COVID and FLU testing for schools, companies, homeless shelters, and nursing homes. The lab also serves as a reference lab for physician offices, and other facilities that lack services for complex virus diagnostics.

SOURCE: Net Medical Xpress Solutions, Inc.

View source version on accesswire.com:
https://www.accesswire.com/689808/Net-Medical-Announces-Preliminary-Results-for-Fourth-Quarter-2021

FAQ

What were the financial results for Net Medical Xpress (NMXS) in Q4 2021?

Net Medical Xpress reported a net income of $301,285 and total revenue of $821,399 for Q4 2021.

What testing methods does Net Medical Xpress use?

Net Medical Xpress uses bioMerieux's proprietary PCR testing module, which is FDA-approved and detects 22 viral pathogens.

How does Net Medical Xpress support COVID testing?

The company operates mobile testing labs that provide statewide COVID and FLU testing for various facilities.